• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanistic analysis of Ivermectin

June 19, 2020COVID-19, Vizit Graphs
Mechanistic analysis of IvermectinEftychia Lekka2020-08-03T13:55:41+00:00
Mechanistic analysis of Ivermectin

Ivermectin is an anti-parasitic agent that has shown promise against the virus in vitro. Its potential mechanism of action (MoA) in COVID-19, is poorly understood.

Explore the live graph.

Tags: A.R.D.S., ABCB1, ACE, ACE2, ALANINE AMINOTRANSFERASE, ALBUMIN, ANTIBODY FORMATION, ASPARTATE AMINOTRANSFERASE, BREATH SHORTNESS, COUGH, CRP, DIARRHEA, DISTRESS RESPIRATORY, IL10, IL1B, IL6, IMMUNITY, IMMUNOCOMPROMISED HOST, INFECTION, INFLAMMATION, INJURY, INTERFERON, ITCH, IVERMECTIN, LDH, LIFE CYCLE STAGES, LUNG INFLAMMATION, MUSCLE STRAIN, MYALGIA, PAIN, RESPIRATION, RNA DEPENDENT RNA POLYMERASE, SARS-COV-2, SPIKE, TNF

Post navigation

← Mechanistic analysis of combination IFB-a2b chlorpheniramine, ibuprofen
Mechanistic analysis of Azithromycin →

Vizit Graphs Tag Cloud

CANCER PARKINSON DISEASE IL2 INTERFERON LISTERIA MONOCYTOGENES IMMUNITY METFORMIN ACE2 INFLAMMATION LACTATE DEHYDROGENASE CANDIDA ALBICANS COAGULATION COGNITION ANGIOTENSIN II COVID-19 PD-1 AGING NEUTROPHILS NFKB1 APOPTOTIC PROCESS SARS-COV-2 TNF ESCHERICHIA COLI ACE CD4 INFLAMMATORY RESPONSE IFNG HELICOBACTER PYLORI TMPRSS2 IL10 CELL DIFFERENTIATION INSULIN RAS PSEUDOMONAS AERUGINOSA MYALGIA IL1B CELL PROLIFERATION RHEUMATOID ARTHRITIS ALBUMIN STAPHYLOCOCCUS AUREUS AUTOPHAGY IMMUNE RESPONSE CASP3 IL6 ALZHEIMER'S DISEASE

© 2021 Biovista Vizit All Rights Reserved.